Renal Cancer
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial - Beyond the Abstract
January 28, 2022
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy - Beyond the Abstract
November 29, 2021
TRIM63 Is a Sensitive and Specific Biomarker for MiT Family Aberration-Associated Renal Cell Carcinoma - Beyond the Abstract
August 5, 2021
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer - Beyond the Abstract
July 28, 2021
Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes - Beyond the Abstract
July 22, 2021